DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Shapiro AD, Ragni M V, Valentino L a. et al.
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in haemophilia B patients.
Blood 2012;
119: 666-672.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.